PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 70 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,545 | -41.7% | 70,231 | -37.9% | 0.00% | -100.0% |
| Q4 2022 | $117,601 | -23.6% | 113,078 | -15.4% | 0.00% | 0.0% |
| Q3 2022 | $154,000 | -6.7% | 133,662 | +51.0% | 0.00% | 0.0% |
| Q2 2022 | $165,000 | -63.8% | 88,502 | -41.2% | 0.00% | -50.0% |
| Q1 2022 | $456,000 | -53.6% | 150,492 | -42.0% | 0.00% | -60.0% |
| Q4 2021 | $982,000 | -23.5% | 259,670 | +4.6% | 0.01% | -28.6% |
| Q3 2021 | $1,284,000 | – | 248,308 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |